ARCHIVES

NLST Suggests 18.5 Percent Of LDCT-Detected Cancers Could Be Indolent

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

DCPC Board Approves Concepts For New Master Agreement, Recompetitions

October 9, 1987

Results of NSABP Studies Unchanged When Falsified Data is Excluded: Fisher

May 27, 1994

Herceptin Regimen Minus Adriamycin Increases Survival With Less Toxicity

October 28, 2011

Shubik Group Finally Completes Document On Carcinogenicity Criteria

March 12, 1976

NCI Offers Mouse Strains, Tissue Microarrays, Online.

March 9, 2001

DCT Board Okays Concepts Of Four New Grant Projects, Four Competitive Contract Delays Chlordane Study

March 9, 1984